PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1408920
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1408920
Cell Sorting Market size was valued at USD 945.67 Million in 2023, expanding at a CAGR of 10.5% from 2024 to 2032.
Sorting cells is a process that involves removing cells from an organism and classifying the cells according to their form. To indicate areas of interest and their impact, the cells are labeled in addition to being marked. Variations in cell size, surface protein expression, and morphology (shape) are used to divide the cells. There are several uses for sorting a heterogeneous combination of biological cells in biotechnology and biopharmaceuticals.
The demand for cell-based therapeutics has grown as chronic illnesses like cancer and diabetes become more common. Cell sorting technology is essential to comprehending these illnesses and developing novel therapies for them. Through the process of cell sorting, medical professionals and scientists may distinguish certain cells from a variety of cell types, providing them with more insights into disease causes, immunological markers, and the development of tailored therapies. Personalized medical techniques and more potent therapies may result from a better understanding of these interconnections. Personalized therapy techniques or biomarker identification can be achieved by isolating particular cell populations using cell sorting. These populations can then be further defined and evaluated. Globally increasing rates of chronic illness are driving up demand for cellular-based treatments including immunotherapies and stem cell therapy. To assure the safety and efficacy of the final cell-based products, cell sorting technology enables the separation and enrichment of certain cell types for use in these therapies. Therefore, throughout the projected period, the worldwide cell sorting market would rise at a faster rate because of the increased demand for cell-based treatments brought on by the increasing incidence of chronic illnesses.
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period due to the large investments in the pharmaceutical and biotechnology sectors and the rising usage of this approach in cancer research, as well as the development of novel treatments in nations such as the United States. Regional expansion is also fueled by the nation's growing rates of infectious illnesses and cancer. The country saw 15.5 million visits to doctor's offices in 2021 with the primary diagnosis of infectious and parasitic disorders, according to the Centers for Disease Control and Prevention. The rising prevalence of cell-sorting disorders and cancer, together with rising healthcare costs nationwide, are driving up market expansion in the area.
The key players operating in the market are: Thermo Fisher Scientific Inc., Sony Biotechnology Inc., Miltenyi Biotec, Union Biometrica, Inc., STEMCELL Technologies Inc., TERUMO BCT, INC., Abgenex, Sysmex Europe GmbH, Sepmag, NanoCellect Biomedical, BD, Bio-Rad Laboratories, Inc., Cytonome/ST, LLC, On-chip Biotechnologies Co., Ltd. Corporation, Beckman Coulter, Inc., Luminex Corporation, pluriSelect Life Science UG (haftungsbeschrankt) & Co. KG, Bay bioscience Co., Ltd. and Cellular Highways among others. These players perform various strategies to capture a major market share. Strategies like merger & acquisition, agreement, collaboration, product launches and others.
In October 2023, Sony Corporation announced the release of the FP7000 spectral cell sorter, which uses fluidics, sophisticated electronics, and unique spectral technology to provide high-speed, high-parameter sorting with over 44 colors and straightforward processes.
The scope of this report covers the market by its major segments, which include as follows: